DexCom (DXCM) stock declines after a short report, yet analysts from TD Cowen and Baird stay bullish on the company's ...

From a pharmaceutical strategy perspective, zimislecel could anchor a premium, disease-modifying segment in high-risk T1D.

ABT's strong Nutrition, Diabetes Care and EPD growth fuel momentum, but macro and currency headwinds challenge its outlook.

Roche (SIX: RO, ROG; OTCQX: RHHBY) shared real-world evidence from the rollout of Accu-Chek SmartGuide continuous glucose ...

Insulet’s chief growth officer said: “colour has the power to differentiate a brand,” with mango orange adorning Omnipod’s ...

Nandita Vijayasimha, Bengaluru Monday, September 15, 2025, 08:00 Hrs [IST] ...

Here are four of the latest recalls and corrections reported to the FDA.

At the 61st annual European Association for the Study of Diabetes Conference (EASD) this week in Vienna, Austria, glucose monitoring company Dexcom introduced its new offering, the Dexcom Smart Basal, ...

Dexcom faces mounting scrutiny over G7 safety concerns, FDA violations, financial practices, and growing competition from ...

A 12-week randomized trial found that remotely delivered Tai Chi significantly enhanced cognitive performance and sleep ...

MDT delivered solid fiscal Q1 2026 results, with 8.4% revenue growth and standout performance in Cardiac Ablation and ...

The global Diabetes Care Devices Market , valued at US$30.8 billion in 2024, stood at US$34.3 billion in 2025 and is ...